|
Index of reports
> Cases resulting in hospitalization (12)
> Cases with Urinary Incontinence (4)
Below is the selection of adverse event reports related to Akineton (Biperiden) that includes cases resulting in hospitalization where reactions include urinary incontinence.
Adverse event in 41 year old male receiving Akineton (Biperiden)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-02-14
Patient: 41 year old male
Adverse reactions / side effects: Confusional State, Urinary Incontinence, Disorientation, Aggression, Loss of Consciousness, Tremor, Sedation, Gait Disturbance
Adverse event resulted in: hospitalization
Suspect drug(s):
Pantozol
Administration route: Oral
Seropram
Administration route: Oral
Start date: 2003-08-04
End date: 2003-08-18
Lithium Carbonate
Administration route: Oral
Start date: 2003-08-04
End date: 2003-08-13
Lithium Carbonate
Administration route: Oral
Start date: 2003-08-14
End date: 2003-08-19
Carbamazepine
Administration route: Oral
Start date: 2003-08-04
End date: 2003-08-18
Carbamazepine
Administration route: Oral
Start date: 2003-08-16
End date: 2003-08-16
Temesta
Clopixol
Administration route: Oral
Akineton
Administration route: Oral
Other drugs received by patient: Ferrum Hausmann
Adverse event in 41 year old male receiving Akineton (Biperiden)
Reported by a individual with unspecified qualification from Switzerland on 2007-02-09
Patient: 41 year old male
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Confusional State, Urinary Incontinence, Disorientation, Aspartate Aminotransferase Decreased, Amnesia, Aggression, Tremor, Haemoglobin Decreased, Gamma-Glutamyltransferase Increased, Sedation, Gait Disturbance, Alanine Aminotransferase Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Temesta
Dosage: 7.5 mg q day unk
Pantozol
Dosage: 40 mg q day po
Administration route: Oral
Akineton
Dosage: 4 mg q day po
Administration route: Oral
Clopixol / 00876701 /
Dosage: 60 mg q day po
Administration route: Oral
Lithium Carbonate
Dosage: 660 mg q day po
Administration route: Oral
Indication: Aggression
Start date: 2003-08-04
End date: 2003-08-13
Lithium Carbonate
Dosage: 1320 mg q day po
Administration route: Oral
Indication: Aggression
Start date: 2003-08-14
End date: 2003-08-19
Seropram / 00582602 /
Dosage: 20 mg q day po
Administration route: Oral
Indication: Aggression
Start date: 2003-08-04
End date: 2003-08-18
Tegretol
Dosage: 200 mg q day po
Administration route: Oral
Indication: Aggression
Start date: 2003-08-04
End date: 2003-08-18
Tegretol
Dosage: 800 mg once po
Administration route: Oral
Indication: Aggression
Start date: 2003-08-16
End date: 2003-08-16
Other drugs received by patient: Ferrum Hausmann / 00023505 /
Adverse event in 41 year old male receiving Akineton (Biperiden)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-02-06
Patient: 41 year old male
Adverse reactions / side effects: Confusional State, Urinary Incontinence, Disorientation, Loss of Consciousness, Tremor, Sedation, Mental Disorder, Gait Disturbance
Adverse event resulted in: hospitalization
Suspect drug(s):
Pantozol
Administration route: Oral
Seropram
Administration route: Oral
Start date: 2003-08-04
End date: 2003-08-18
Lithium Carbonate
Administration route: Oral
Start date: 2003-08-04
End date: 2003-08-13
Lithium Carbonate
Administration route: Oral
Start date: 2003-08-14
End date: 2003-08-19
Carbamazepine
Administration route: Oral
Start date: 2003-08-04
End date: 2003-08-18
Carbamazepine
Administration route: Oral
Start date: 2003-08-16
End date: 2003-08-16
Temesta
Clopixol
Administration route: Oral
Akineton
Administration route: Oral
Other drugs received by patient: Ferrum Hausmann
Adverse event in 41 year old male receiving Akineton (Biperiden)
Reported by a individual with unspecified qualification from Germany on 2007-02-06
Patient: 41 year old male
Adverse reactions / side effects: Confusional State, Blood Alkaline Phosphatase Decreased, Urinary Incontinence, Disorientation, Tremor, Haemoglobin Decreased, Haematocrit Decreased, Gamma-Glutamyltransferase Increased, Sedation, Coordination Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Tegretol
Dosage: 200 mg/day
Indication: Aggression
Start date: 2003-08-04
End date: 2003-08-18
Tegretol
Dosage: 800 mg/day
Administration route: Oral
Start date: 2003-08-16
End date: 2003-08-16
Seropram
Dosage: 20 mg/day
Administration route: Oral
Indication: Aggression
Start date: 2003-08-04
End date: 2003-08-18
Lithium Carbonate
Dosage: 660 mg/day
Administration route: Oral
Indication: Aggression
Start date: 2003-08-04
End date: 2003-08-13
Lithium Carbonate
Dosage: 1320 mg/day
Administration route: Oral
Start date: 2003-08-14
End date: 2003-08-19
Clopixol
Dosage: 60 mg/day
Administration route: Oral
Temesta
Dosage: 7.5 mg/day
Akineton
Dosage: 4 mg/day
Administration route: Oral
Pantozol
Dosage: 40 mg/day
Administration route: Oral
Other drugs received by patient: Ferrum Hausmann
|
